menu
    • menu

    Company profile for Dalton Pharma Services

    NEW Drugs in Dev: 3
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    SERVICES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dalton Pharma Services is a Health Canada approved and FDA registered GMP contract provider of integrated chemistry, drug development and manufacturing services to the pharmaceutical and biotechnology industries. We bring 30 years of experience to our client's projects and emphasize quality, speed and flexibility. Our full range of services in-house (drug discovery, flow chemistry, formulation and process development, custom s...
    Dalton Pharma Services is a Health Canada approved and FDA registered GMP contract provider of integrated chemistry, drug development and manufacturing services to the pharmaceutical and biotechnology industries. We bring 30 years of experience to our client's projects and emphasize quality, speed and flexibility. Our full range of services in-house (drug discovery, flow chemistry, formulation and process development, custom synthesis, cGMP sterile fill/finish, cGMP API manufacturing and/or dosage form manufacturing) all at one location enables us to be adaptable, flexible and cost-effective.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dalton Pharma ServicesCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Dalton Pharma Services 349 Wildcat Rd. Toronto
    Telephone
    Telephone
    (416) 661-2102
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.dalton.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dalton-pharma-services/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Onco-Innovations Advances API Synthesis for ONC010
    Onco-Innovations Advances API Synthesis for ONC010

    19 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-19/onco-innovations-reports-continued-advancement-of-key-materials-used-in-the-synthesis-of-its-active

    PHARMIWEB
    19 May 2026
    Share Share
    Onco-Inno Boosts PNKP Inhibitor Production With Dalton Pharma
    Onco-Inno Boosts PNKP Inhibitor Production With Dalton Pharma

    01 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-01/onco-innovations-expands-manufacturing-scale-up-of-its-pnkp-inhibitor-technology-with-dalton-pharma

    PHARMIWEB
    01 May 2026
    Share Share
    Dalton Expands Aseptic Powder Fill-Finish Capacity with RoboFil
    Dalton Expands Aseptic Powder Fill-Finish Capacity with RoboFil

    31 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dalton-pharma-services-expands-aseptic-powder-fill-finish-capacity-with-robofil-system-in-toronto-302728646.html

    PR NEWSWIRE
    31 Mar 2026
    Share Share
    Onco-Innovations Boosts PNKP Inhibitor Tech With Dalton Pharma
    Onco-Innovations Boosts PNKP Inhibitor Tech With Dalton Pharma

    20 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-20/onco-innovations-advances-optimization-and-scale-up-of-its-pnkp-inhibitor-technology-with-dalton-pha

    PHARMIWEB
    20 Nov 2025
    Share Share
    Onco-Innovations, Dalton Pharma Start Nanoparticle Production
    Onco-Innovations, Dalton Pharma Start Nanoparticle Production

    19 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-19/onco-innovations-commences-activities-to-manufacture-nanoparticle-formulation-with-dalton-pharma-to

    PHARMAWEB
    19 Sep 2025
    Share Share
    Onco-Innovations Starts Manufacture Preclinical Testing Material
    Onco-Innovations Starts Manufacture Preclinical Testing Material

    26 May 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/onco-innovations-announces-start-of-manufacturing-of-preclinical-test-1032039

    ACCESSWIRE
    26 May 2025
    Share Share

    Drugs in Development

    read-more
    read-more
    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke Program

    Details:

    Algernon Pharmaceuticals has awarded the contract to manufacture the active pharmaceutical ingredient and finished product for its formulation of AP-188 (“N,N-Dimethyltryptamine or DMT”), to Canadian-based Dalton Pharma Services.


    Lead Product(s): Dimethyltryptamine

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

    Study Phase: PreclinicalProduct Type: Controlled Substance

    Sponsor: Algernon Pharmaceuticals

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Collaboration February 19, 2021

    blank

    01

    Dalton Pharma Services

    Canada
    arrow
    PEGS Boston Summit
    Not Confirmed

    Dalton Pharma Services

    Canada
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Dimethyltryptamine

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Preclinical

    Partner/Sponsor/Collaborator : Algernon Pharmaceuticals

    Deal Size : Undisclosed

    Deal Type : Collaboration

    DEALS_DEV arrow-down

    Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke Program

    Details : Algernon Pharmaceuticals has awarded the contract to manufacture the active pharmaceutical ingredient and finished product for its formulation of AP-188 (“N,N-Dimethyltryptamine or DMT”), to Canadian-based Dalton Pharma Services.

    Product Name : Undisclosed

    Product Type : Controlled Substance

    Upfront Cash : Undisclosed

    February 19, 2021

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dalton, VIDO-InterVac Partner to Develop COVID-19 Vax

    Details:

    Under this Partnership, Dalton will be responsible for the formulation and fill/finish of VIDO-InterVac’s COVID-19 vaccine to be used in early Phase clinical trials from Dalton`s cGMP biopharmaceutical facility in Toronto, Canada.


    Lead Product(s): COVID-19 Vaccine

    Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Vaccine

    Sponsor: VIDO-InterVac

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership July 28, 2020

    blank

    02

    Dalton Pharma Services

    Canada
    arrow
    PEGS Boston Summit
    Not Confirmed

    Dalton Pharma Services

    Canada
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : COVID-19 Vaccine

    Therapeutic Area : Infections and Infectious Diseases

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : VIDO-InterVac

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Dalton, VIDO-InterVac Partner to Develop COVID-19 Vax

    Details : Under this Partnership, Dalton will be responsible for the formulation and fill/finish of VIDO-InterVac’s COVID-19 vaccine to be used in early Phase clinical trials from Dalton`s cGMP biopharmaceutical facility in Toronto, Canada.

    Product Name : Undisclosed

    Product Type : Vaccine

    Upfront Cash : Undisclosed

    July 28, 2020

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dalton Expands Cannabinoids Capabilities

    Details:

    Dalton receives the license amendment from Health Canada under Cannabis regulations enabling transfer of finished cGMP cannabis products to licensed dealers.


    Lead Product(s): Cannabidiol

    Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

    Study Phase: Approved FDFProduct Type: Controlled Substance

    Sponsor: Health Canada

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Licensing Agreement January 15, 2020

    blank

    03

    Dalton Pharma Services

    Canada
    arrow
    PEGS Boston Summit
    Not Confirmed

    Dalton Pharma Services

    Canada
    arrow
    PEGS Boston Summit
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Cannabidiol

    Therapeutic Area : Cardiology/Vascular Diseases

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Health Canada

    Deal Size : Undisclosed

    Deal Type : Licensing Agreement

    DEALS_DEV arrow-down

    Dalton Expands Cannabinoids Capabilities

    Details : Dalton receives the license amendment from Health Canada under Cannabis regulations enabling transfer of finished cGMP cannabis products to licensed dealers.

    Product Name : Undisclosed

    Product Type : Controlled Substance

    Upfront Cash : Undisclosed

    January 15, 2020

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    Analytical

    Click here to discover the service providers for Analytical

    Stability Studies

    read-more
    read-more

    01

    02

    LONG-TERM STABILITY TESTING

    LONG-TERM STABILITY TESTING

    arrow
    PEGS Boston Summit
    Not Confirmed

    03

    INTERMEDIATE STABILITY TESTING

    INTERMEDIATE STABILITY TESTING

    arrow
    PEGS Boston Summit
    Not Confirmed

    04

    05

    FORCED DEGRADATION STUDIES

    FORCED DEGRADATION STUDIES

    arrow
    PEGS Boston Summit
    Not Confirmed

    06

    07

    COMMERCIAL PRODUCT STABILITY TESTING

    COMMERCIAL PRODUCT STABILITY TESTING

    arrow
    PEGS Boston Summit
    Not Confirmed

    08

    COMPARATOR STABILITY TESTING

    COMPARATOR STABILITY TESTING

    arrow
    PEGS Boston Summit
    Not Confirmed

    09

    PHOTOSTABILITY

    PHOTOSTABILITY

    arrow
    PEGS Boston Summit
    Not Confirmed
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search